Lang, A.; Oehler, D.; Benkhoff, M.; Reinders, Y.; Barcik, M.; Shahrjerdi, K.; Kaldirim, M.; Sickmann, A.; Dannenberg, L.; Polzin, A.;
et al. Mitochondrial Creatine Kinase 2 (Ckmt2) as a Plasma-Based Biomarker for Evaluating Reperfusion Injury in Acute Myocardial Infarction. Biomedicines 2024, 12, 2368.
https://doi.org/10.3390/biomedicines12102368
AMA Style
Lang A, Oehler D, Benkhoff M, Reinders Y, Barcik M, Shahrjerdi K, Kaldirim M, Sickmann A, Dannenberg L, Polzin A,
et al. Mitochondrial Creatine Kinase 2 (Ckmt2) as a Plasma-Based Biomarker for Evaluating Reperfusion Injury in Acute Myocardial Infarction. Biomedicines. 2024; 12(10):2368.
https://doi.org/10.3390/biomedicines12102368
Chicago/Turabian Style
Lang, Alexander, Daniel Oehler, Marcel Benkhoff, Yvonne Reinders, Maike Barcik, Khatereh Shahrjerdi, Madlen Kaldirim, Albert Sickmann, Lisa Dannenberg, Amin Polzin,
and et al. 2024. "Mitochondrial Creatine Kinase 2 (Ckmt2) as a Plasma-Based Biomarker for Evaluating Reperfusion Injury in Acute Myocardial Infarction" Biomedicines 12, no. 10: 2368.
https://doi.org/10.3390/biomedicines12102368
APA Style
Lang, A., Oehler, D., Benkhoff, M., Reinders, Y., Barcik, M., Shahrjerdi, K., Kaldirim, M., Sickmann, A., Dannenberg, L., Polzin, A., Pfeiler, S., Kelm, M., Grandoch, M., Jung, C., & Gerdes, N.
(2024). Mitochondrial Creatine Kinase 2 (Ckmt2) as a Plasma-Based Biomarker for Evaluating Reperfusion Injury in Acute Myocardial Infarction. Biomedicines, 12(10), 2368.
https://doi.org/10.3390/biomedicines12102368
